01 · ABSTRACT
Abstract
Intravesical capsaicin has been used as a treatment for detrusor overactivity and bladder pain syndromes due to its desensitizing effect on C-fiber afferents. However, patient responses vary widely in both efficacy and tolerability. As a therapeutic option, intravesical capsaicin has largely been replaced by botulinum toxin. However, the drug may still be considered in select cases of refractory disease or within the context of research protocols.
02 · PUBLICATION RECORD
Article details
JournalMedical Research Archives
IssueVol 13 No 9 (2025): Vol.13, Issue 9, September 2025
SectionResearch Articles
Published25 September 2025
DOI10.18103/mra.v13i9.6940
ISSN2375-1924
03 · RIGHTS & REUSE
Rights & reuse
This article is published under a Creative Commons Attribution License (CC BY 3.0) and may be shared or distributed by anyone as long as attribution is given to the journal.